Serapen, Sheila Mae V.

HRN: 29-11-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
METRONIDAZOLE 500MG (TAB)
06/21/2026
07/04/2026
PO
500mg
TID
NSVD THICKLY MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: